Literature DB >> 20305094

Managing chromoblastomycosis.

Mahreen Ameen1.   

Abstract

Chromoblastomycosis is a subcutaneous fungal infection caused by the traumatic inoculation of the skin with pigmented saprophytic moulds. Although infection is rarely fatal, it is characteristically chronic and can be complicated by lymphatic damage and malignant transformation. Despite a variety of treatment modalities, which are often combined and include long courses of antifungals, surgical excision and destructive physical therapies, it remains one of the most difficult deep mycotic infections to eradicate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305094     DOI: 10.1258/td.2009.090264

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  13 in total

1.  Subcutaneous fungal infections.

Authors:  Ricardo M La Hoz; John W Baddley
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

2.  1,10-phenanthroline inhibits the metallopeptidase secreted by Phialophora verrucosa and modulates its growth, morphology and differentiation.

Authors:  Marcela Queiroz Granato; Priscila de Araújo Massapust; Sonia Rozental; Celuta Sales Alviano; André Luis Souza dos Santos; Lucimar Ferreira Kneipp
Journal:  Mycopathologia       Date:  2014-12-12       Impact factor: 2.574

3.  Chromoblastomycosis: tissue modifications during itraconazole treatment.

Authors:  Kátia Sheylla Malta Purim; Murilo Calvo Peretti; José Fillus; Marcia Olandoski
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

4.  Chromoblastomycosis in Western Thailand.

Authors:  Philip McDaniel; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

5.  Three isothermal amplification techniques for rapid identification of Cladophialophora carrionii, an agent of human chromoblastomycosis.

Authors:  Shuwen Deng; G Sybren de Hoog; Weihua Pan; Min Chen; A H G Gerrits van den Ende; Liyue Yang; Jiufeng Sun; Mohammad Javad Najafzadeh; Wanqing Liao; Ruoyu Li
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

6.  A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.

Authors:  Tatiane Caroline Daboit; Cibele Massotti Magagnin; Daiane Heidrich; Mauricio Ramírez Castrillón; Sandra Denise Camargo Mendes; Gerson Vettorato; Patrícia Valente; Maria Lúcia Scroferneker
Journal:  Mycopathologia       Date:  2013-05-04       Impact factor: 2.574

Review 7.  Chromoblastomycosis.

Authors:  Paweł M Krzyściak; Małgorzata Pindycka-Piaszczyńska; Michał Piaszczyński
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

8.  1,10-Phenanthroline-5,6-Dione-Based Compounds Are Effective in Disturbing Crucial Physiological Events of Phialophora verrucosa.

Authors:  Marcela Queiroz Granato; Diego de Souza Gonçalves; Sergio Henrique Seabra; Malachy McCann; Michael Devereux; André Luis Souza Dos Santos; Lucimar Ferreira Kneipp
Journal:  Front Microbiol       Date:  2017-01-30       Impact factor: 5.640

Review 9.  Chromoblastomycosis in India: Review of 169 cases.

Authors:  Reshu Agarwal; Gagandeep Singh; Arnab Ghosh; Kaushal Kumar Verma; Mragnayani Pandey; Immaculata Xess
Journal:  PLoS Negl Trop Dis       Date:  2017-08-03

10.  Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.

Authors:  Bilin Dong; Zhongsheng Tong; Ruoyu Li; Sharon C-A Chen; Weihuang Liu; Wei Liu; Yao Chen; Xu Zhang; Yiqun Duan; Dongsheng Li; Liuqing Chen
Journal:  PLoS Negl Trop Dis       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.